GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » Beneish M-Score

JD Health International (HKSE:06618) Beneish M-Score : -2.10 (As of May. 02, 2024)


View and export this data going back to 2020. Start your Free Trial

What is JD Health International Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.1 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for JD Health International's Beneish M-Score or its related term are showing as below:

HKSE:06618' s Beneish M-Score Range Over the Past 10 Years
Min: -2.75   Med: -2.1   Max: 28.72
Current: -2.1

During the past 7 years, the highest Beneish M-Score of JD Health International was 28.72. The lowest was -2.75. And the median was -2.10.


JD Health International Beneish M-Score Historical Data

The historical data trend for JD Health International's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JD Health International Beneish M-Score Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial 28.72 -2.23 -2.75 -0.52 -2.10

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.75 - -0.52 - -2.10

Competitive Comparison of JD Health International's Beneish M-Score

For the Medical Care Facilities subindustry, JD Health International's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JD Health International's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where JD Health International's Beneish M-Score falls into.



JD Health International Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of JD Health International for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.329+0.528 * 0.9548+0.404 * 3.6267+0.892 * 1.1218+0.115 * 0.7088
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9341+4.679 * -0.038311-0.327 * 0.8502
=-2.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$786 Mil.
Revenue was HK$58,550 Mil.
Gross Profit was HK$12,978 Mil.
Total Current Assets was HK$52,337 Mil.
Total Assets was HK$70,317 Mil.
Property, Plant and Equipment(Net PPE) was HK$811 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$249 Mil.
Selling, General, & Admin. Expense(SGA) was HK$5,090 Mil.
Total Current Liabilities was HK$15,953 Mil.
Long-Term Debt & Capital Lease Obligation was HK$131 Mil.
Net Income was HK$2,343 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$5,037 Mil.
Total Receivables was HK$2,130 Mil.
Revenue was HK$52,191 Mil.
Gross Profit was HK$11,046 Mil.
Total Current Assets was HK$63,035 Mil.
Total Assets was HK$68,429 Mil.
Property, Plant and Equipment(Net PPE) was HK$787 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$157 Mil.
Selling, General, & Admin. Expense(SGA) was HK$4,857 Mil.
Total Current Liabilities was HK$18,265 Mil.
Long-Term Debt & Capital Lease Obligation was HK$144 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(786.384 / 58549.919) / (2130.41 / 52190.947)
=0.013431 / 0.04082
=0.329

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(11045.993 / 52190.947) / (12978.054 / 58549.919)
=0.211646 / 0.221658
=0.9548

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (52337.2 + 810.93) / 70317.185) / (1 - (63035.373 + 786.939) / 68429.258)
=0.244166 / 0.067324
=3.6267

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=58549.919 / 52190.947
=1.1218

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(157.095 / (157.095 + 786.939)) / (248.789 / (248.789 + 810.93))
=0.166408 / 0.234769
=0.7088

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(5089.735 / 58549.919) / (4856.92 / 52190.947)
=0.08693 / 0.093061
=0.9341

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((130.631 + 15952.764) / 70317.185) / ((143.789 + 18265.158) / 68429.258)
=0.228726 / 0.269022
=0.8502

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2342.7 - 0 - 5036.609) / 70317.185
=-0.038311

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

JD Health International has a M-score of -2.10 suggests that the company is unlikely to be a manipulator.


JD Health International Beneish M-Score Related Terms

Thank you for viewing the detailed overview of JD Health International's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


JD Health International (HKSE:06618) Business Description

Traded in Other Exchanges
Address
No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.

JD Health International (HKSE:06618) Headlines

No Headlines